XML 57 R32.htm IDEA: XBRL DOCUMENT v3.4.0.3
Restatement of Previously Filed Financial Information (Tables)
12 Months Ended
Dec. 31, 2015
Accounting Changes and Error Corrections [Abstract]  
Schedule of the effects of the financial statement adjustments related to the restatement

 

The effect of the restatement on the previously filed condensed consolidated balance sheet as of December 31, 2014 is as follows, in thousands:

 

 

 

December 31, 2014

 

 

 

As Previously 
Reported

 

Restatement 
Adjustment

 

 

 

As Restated

 

ASSETS

 

 

 

 

 

 

 

 

 

CURRENT ASSETS

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

70,680

 

$

(1

)

(i)

 

$

70,679

 

Trade accounts receivable, net

 

220,716

 

(33,171

)

(a), (b), (c)

 

187,545

 

Inventories, net

 

131,310

 

3,887

 

(d), (f)

 

135,197

 

Deferred taxes, current

 

33,480

 

4,931

 

(e), (i)

 

38,411

 

Available for sale security, current

 

7,268

 

 

 

 

7,268

 

Prepaid expenses and other current assets

 

30,875

 

6,186

 

(c), (d), (e)

 

37,061

 

 

 

 

 

 

 

 

 

 

 

TOTAL CURRENT ASSETS

 

494,329

 

(18,168

)

 

 

476,161

 

PROPERTY, PLANT AND EQUIPMENT, NET

 

143,788

 

408

 

(c), (d)

 

144,196

 

OTHER LONG-TERM ASSETS

 

 

 

 

 

 

 

 

 

Goodwill

 

278,774

 

6,509

 

(e)

 

285,283

 

Product licensing rights, net

 

704,218

 

573

 

(e)

 

704,791

 

Other intangibles, net

 

259,141

 

(3,529

)

(e)

 

255,612

 

Deferred financing costs, net

 

21,560

 

2,144

 

(c), (d), (h)

 

23,704

 

Deferred taxes, non-current

 

3,020

 

(936

)

(i)

 

2,084

 

Long-term investments

 

208

 

3

 

(i)

 

211

 

Other non-current assets

 

1,863

 

 

 

 

1,863

 

 

 

 

 

 

 

 

 

 

 

TOTAL OTHER LONG-TERM ASSETS

 

1,268,784

 

4,764

 

 

 

1,273,548

 

 

 

 

 

 

 

 

 

 

 

TOTAL ASSETS

 

$

1,906,901

 

$

(12,996

)

 

 

$

1,893,905

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

CURRENT LIABILITIES

 

 

 

 

 

 

 

 

 

Trade accounts payable

 

$

44,116

 

$

3,201

 

(c), (d)

 

$

47,317

 

Purchase consideration payable, current

 

7,481

 

3,489

 

(e)

 

10,970

 

Income taxes payable

 

1

 

(1)

 

(i)

 

 

Accrued royalties

 

13,041

 

163

 

(d)

 

13,204

 

Accrued compensation

 

13,467

 

 

 

 

13,467

 

Current maturities of long-term debt

 

10,450

 

 

 

 

10,450

 

Accrued administrative fees

 

27,774

 

13,096

 

(b), (d)

 

40,870

 

Accrued expenses and other liabilities

 

17,835

 

(3,259

)

(c), (d), (e)

 

14,576

 

 

 

 

 

 

 

 

 

 

 

TOTAL CURRENT LIABILITIES

 

134,165

 

16,689

 

 

 

150,854

 

LONG-TERM LIABILITIES

 

 

 

 

 

 

 

 

 

Long-term debt

 

1,114,481

 

 

 

 

1,114,481

 

Deferred tax liability, non-current

 

268,968

 

460

 

(e)

 

269,428

 

Lease incentive obligations and other long-term liabilities

 

2,536

 

300

 

(c), (d)

 

2,836

 

 

 

 

 

 

 

 

 

 

 

TOTAL LONG-TERM LIABILITIES

 

1,385,985

 

759

 

 

 

1,386,745

 

 

 

 

 

 

 

 

 

 

 

TOTAL LIABILITIES

 

1,520,150

 

17,448

 

 

 

1,537,599

 

 

 

 

 

 

 

 

 

 

 

SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

Common stock, no par value — 150,000,000 shares authorized; 111,734,901 shares issued and outstanding at December 31, 2014

 

351,235

 

(8,983

)

(i)

 

342,252

 

Warrants to acquire common stock

 

 

 

 

 

 

Retained earnings

 

50,711

 

(21,461

)

(a), (b), (c), (d), (e), (f)

 

29,250

 

Accumulated other comprehensive loss

 

(15,195

)

 

 

 

(15,195

)

 

 

 

 

 

 

 

 

 

 

TOTAL SHAREHOLDERS’ EQUITY

 

386,751

 

(30,444

)

 

 

356,307

 

 

 

 

 

 

 

 

 

 

 

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

 

$

1,906,901

 

$

(12,996

)

 

 

$

1,893,905

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The effect of the restatement on the previously filed consolidated income statement for the year ended December 31, 2014 is as follows, in thousands except per share amounts:

 

 

 

Year ended December 31, 2014

 

 

 

As Previously 
Reported

 

Restatement 
Adjustment

 

 

 

As Restated

 

REVENUES

 

$

593,078

 

$

(38,030

)

(a), (b), (c)

 

$

555,048

 

Cost of sales (exclusive of amortization of intangibles, included within operating expenses below)

 

295,488

 

(1,800

)

(c), (d), (f)

 

293,688

 

 

 

 

 

 

 

 

 

 

 

GROSS PROFIT

 

297,590

 

(36,230

)

 

 

261,360

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

95,463

 

(2,508

)

(c), (d)

 

92,955

 

Acquisition-related costs

 

32,147

 

693

 

(c), (d)

 

32,840

 

Research and development expenses

 

29,199

 

2,057

 

(c), (d)

 

31,256

 

Amortization of intangibles

 

44,066

 

(573

)

(e)

 

43,493

 

 

 

 

 

 

 

 

 

 

 

TOTAL OPERATING EXPENSES

 

200,875

 

(331

)

 

 

200,544

 

 

 

 

 

 

 

 

 

 

 

OPERATING INCOME

 

96,715

 

(35,899

)

 

 

60,816

 

 

 

 

 

 

 

 

 

 

 

Amortization of deferred financing costs

 

(12,129

)

2,144

 

(c), (d), (h)

 

(9,985

)

Interest expense, net

 

(35,657

)

 

 

 

(35,657

)

Gain from product divestiture

 

9,807

 

(510

)

(e)

 

9,297

 

Other non-operating income, net

 

400

 

471

 

(c), (d)

 

871

 

 

 

 

 

 

 

 

 

 

 

INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES

 

59,136

 

(33,794

)

 

 

25,342

 

Income tax provision

 

23,288

 

(12,334

)

(i)

 

10,954

 

 

 

 

 

 

 

 

 

 

 

INCOME FROM CONTINUING OPERATIONS

 

$

35,848

 

$

(21,460

)

 

 

$

14,388

 

Loss from discontinued operations, net of tax

 

$

(503

)

$

(1

)

(i)

 

$

(504

)

 

 

 

 

 

 

 

 

 

 

 

 

 

CONSOLIDATED NET INCOME

 

$

35,345

 

$

(21,461

)

 

 

$

13,884

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CONSOLIDATED NET INCOME PER COMMON SHARE:

 

 

 

 

 

 

 

 

 

Income from continuing operations, basic

 

$

0.35

 

$

(0.21

)

 

 

$

0.14

 

Loss from discontinued operations, basic

 

$

(0.01

)

$

 

 

 

$

(0.01

)

 

 

 

 

 

 

 

 

 

 

 

 

 

CONSOLIDATED NET INCOME, BASIC

 

$

0.34

 

$

(0.21

)

 

 

$

0.13

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income from continuing operations, diluted

 

$

0.34

 

$

(0.21

)

 

 

$

0.13

 

Loss from discontinued operations, diluted

 

$

(0.01

)

$

0.01

 

 

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CONSOLIDATED NET INCOME, DILUTED

 

$

0.33

 

$

(0.20

)

 

 

$

0.13

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SHARES USED IN COMPUTING CONSOLIDATED NET INCOME PER COMMON SHARE:

 

 

 

 

 

 

 

 

 

BASIC

 

103,480

 

 

 

 

103,480

 

 

 

 

 

 

 

 

 

 

 

DILUTED

 

123,110

 

(13,522)

 

 

 

109,588

 

 

 

 

 

 

 

 

 

 

 

COMPREHENSIVE INCOME:

 

 

 

 

 

 

 

 

 

Consolidated net income

 

$

35,345

 

$

(21,461

)

 

 

$

13,884

 

Unrealized holding loss on available-for-sale securities, net of tax of $663

 

(1,124

)

 

 

 

(1,124

)

Foreign currency translation loss, net of tax of $877 for the year ended December 31, 2014

 

(1,704

)

 

 

 

(1,704

)

 

 

 

 

 

 

 

 

 

 

COMPREHENSIVE INCOME

 

$

32,517

 

$

(21,461

)

 

 

$

11,056

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The effect of the restatement on the previously filed consolidated statement of cash flows for the year ended December 31, 2014 is as follows, in thousands:

 

 

 

Year ended December 31, 2014

 

 

 

As Previously 
Reported

 

Restatement 
Adjustment

 

 

 

As Restated

 

OPERATING ACTIVITIES:

 

 

 

 

 

 

 

 

 

Consolidated net income

 

$

35,345

 

$

(21,461

)

(a), (b), (c), (d), (e), (f)

 

$

13,884

 

Loss from discontinued operations, net of tax

 

503

 

1

 

(i)

 

504

 

Adjustments to reconcile consolidated net income to net cash provided by operating activities:

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

58,538

 

(707

)

(c), (d)

 

57,831

 

Amortization of deferred financing fees

 

12,129

 

(2,145

)

(c), (d), (h)

 

9,984

 

Amortization of favorable (unfavorable) contracts

 

72

 

(1

)

(i)

 

71

 

Amortization of inventory step-up

 

20,798

 

 

 

 

20,798

 

Non-cash stock compensation expense

 

7,542

 

210

 

(i)

 

7,752

 

Non-cash interest expense

 

4,871

 

 

 

 

4,871

 

Non-cash gain on bargain purchase

 

 

 

 

 

 

Gain from product divestiture

 

(9,807

)

478

 

(e)

 

(9,329

)

Deferred income taxes, net

 

25,293

 

(42,804

)

(e)

 

(17,511

)

Excess tax benefit from stock compensation

 

(38,710

)

9,193

 

(e)

 

(29,517

)

Non-cash settlement of product warranty liability

 

 

 

 

 

 

Equity in earnings of unconsolidated joint venture

 

 

 

 

 

 

Loss on extinguishment of debt

 

990

 

 

 

 

990

 

Gain on sale of available for sale security

 

(7

)

 

 

 

(7

)

Changes in operating assets and liabilities, net of business acquisitions:

 

 

 

 

 

 

 

 

 

Trade accounts receivable, net

 

(95,470

)

22,674

 

(a), (b), (c)

 

(72,796

)

Inventories, net

 

(15,262

)

(4,123

)

(c), (d), (f)

 

(19,385

)

Prepaid expenses and other current assets

 

(13,180

)

43,552

 

(c), (d)

 

30,372

 

Trade accounts payable

 

11,024

 

2,939

 

(c), (d)

 

13,963

 

Accrued expenses and other liabilities

 

26,249

 

1,718

 

(c), (d)

 

27,967

 

 

 

 

 

 

 

 

 

 

 

NET CASH PROVIDED BY OPERATING ACTIVITIES

 

30,918

 

9,254

 

 

 

40,442

 

INVESTING ACTIVITIES:

 

 

 

 

 

 

 

 

 

Payments for acquisitions and equity investments, net of cash acquired

 

(987,802

)

374

 

(e)

 

(987,428

)

Proceeds from disposal of assets

 

59,361

 

___

 

(e)

 

59,361

 

Payments for other intangible assets

 

(8,532

)

(376

)

(c), (d)

 

(8,908

)

Purchases of property, plant and equipment

 

(29,568

)

(331

)

(c), (d)

 

(29,899

)

Distributions from unconsolidated joint venture

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NET CASH USED IN INVESTING ACTIVITIES

 

(966,541

)

(333)

 

 

 

(966,874

)

FINANCING ACTIVITIES:

 

 

 

 

 

 

 

 

 

Proceeds from issuances of debt

 

1,045,000

 

 

 

 

1,045,000

 

Proceeds under stock option and stock purchase plans

 

8,842

 

 

 

 

8,842

 

Payments of contingent acquisition liabilities

 

(15,000

)

 

 

 

(15,000

)

Debt financing costs

 

(28,366

)

1

 

(i)

 

(28,365

)

Proceeds from warrant exercises

 

8,171

 

 

 

 

8,171

 

Excess tax benefits from stock compensation

 

38,710

 

(9,193

)

(i)

 

29,517

 

Debt repayment

 

(85,049

)

 

 

 

(85,049

)

 

 

 

 

 

 

 

 

 

 

NET CASH PROVIDED BY FINANCING ACTIVITIES

 

972,308

 

(9,192

)

 

 

963,116

 

 

 

 

 

 

 

 

 

 

 

Effect of changes in exchange rates on cash and cash equivalents

 

(183

)

 

 

 

(183

)

 

 

 

 

 

 

 

 

 

 

INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

 

36,502

 

(1

)

 

 

36,501

 

CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR

 

34,178

 

 

 

 

34,178

 

 

 

 

 

 

 

 

 

 

 

CASH AND CASH EQUIVALENTS AT END OF YEAR

 

$

70,680

 

$

(1

)

 

 

$

70,679